Intellia Therapeutics Inc. - SCHEDULE 13G/A Filing

This filing is an amendment to a Schedule 13G, filed by The Vanguard Group, Inc. concerning Intellia Therapeutics Inc. The filing indicates that as of March 13, 2026, The Vanguard Group, Inc. no longer holds a significant beneficial ownership in Intellia Therapeutics Inc., with the reported ownership percentage and number of shares being 0. This change is attributed to an internal realignment within The Vanguard Group, Inc. as of January 12, 2026, where certain subsidiaries now report beneficial ownership separately. These subsidiaries continue to pursue the same investment strategies. The filing also includes standard certifications regarding the ordinary course of business for the acquired and held securities.